CHARLES SMITH: Open Payments
NPI 1538363239 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 31 payments from 14 companies in 2025. Trend: 2023 $2,030 · 2024 $1,606 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $137 |
| Janssen Biotech, Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Daiichi Sankyo Inc. | 2 | $46 |
| SOBI, INC | 2 | $43 |
| Kite Pharma, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| PharmaEssentia USA Corporation | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| Genentech USA, Inc. | 1 | $26 |
Products named: VENCLEXTA, EPKINLY, Enhertu, Vonjo, KISQALI, Yescarta, RYBREVANT, LIBTAYO.
Industry payments across AL — which companies pay providers there.
